Interact to see
Advertisement
Advertisement
NSFLX vs RCMTX
NSFLX vs RCMTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
NSFLX vs. RCMTX commentary
Jul 05, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSFLX is a StrongBuy and RCMTX is a Hold.
FUNDAMENTALS
Fundamentals
RCMTX has more cash in the bank: 27.3B vs. NSFLX (13.5M). NSFLX pays higher dividends than RCMTX: NSFLX (1.29) vs RCMTX (0.58). NSFLX was incepted earlier than RCMTX: NSFLX (8 years) vs RCMTX (15 years). NSFLX (1.43) is less costly to investors than RCMTX (1.03). NSFLX is a more actively managed with annual turnover of: 25.00 vs. RCMTX (5.00). RCMTX has a lower initial minimum investment than NSFLX: RCMTX (250) vs NSFLX (1000000). RCMTX annual gain was more profitable for investors over the last year : 12.73 vs. NSFLX (7.56). RCMTX return over 5 years is better than : 46.18 vs. NSFLX (32.71).
| NSFLX | RCMTX | NSFLX / RCMTX | |
| Total Expense Ratio | 0.49 | 1.03 | 48% |
| Annual Report Gross Expense Ratio | 1.43 | 1.03 | 139% |
| Fund Existence | 8 years | 15 years | - |
| Gain YTD | 6.257 | 11.072 | 57% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13.5M | 27.3B | 0% |
| Annual Yield % from dividends | 1.29 | 0.58 | 224% |
| Returns for 1 year | 7.56 | 12.73 | 59% |
| Returns for 3 years | 40.75 | 42.19 | 97% |
| Returns for 5 years | 32.71 | 46.18 | 71% |
| Returns for 10 years | N/A | 83.56 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSPF | 77.62 | 1.03 | +1.34% |
| Invesco S&P 500® Equal Weight Fincl ETF | |||
| EDC | 40.36 | 0.52 | +1.31% |
| Direxion Daily MSCI Em Mkts Bull 3X ETF | |||
| TCHP | 45.62 | 0.46 | +1.02% |
| T. Rowe Price Blue Chip Growth ETF | |||
| HELX | 28.05 | N/A | N/A |
| Franklin Genomic Advancements ETF | |||
| IBGA | 24.49 | -0.09 | -0.36% |
| iShares iBonds Dec 2044 Term Trsy ETF | |||